Kamada (KMDA) Change in Accured Expenses (2012 - 2026)
Kamada (KMDA) reported Change in Accured Expenses of -$1.9 million for Q1 2026, up 7.19% on a YoY basis from -$1.8 million in Q1 2025, and down 257.69% quarter-over-quarter from $1.2 million in Q4 2025.
Kamada (KMDA) Change in Accured Expenses (2012 - 2026) Analysis & Trends
Kamada has reported Change in Accured Expenses for 15 years, with the latest figure at -$1.9 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 7.19% year-over-year to -$1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 22.75% YoY), and the FY2025 full-year result was $950000.0, down 32.77% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$1.9 million, down from $1.2 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $1.6 million in Q4 2024, with the low at -$2.1 million in Q1 2024.
- Historically, Change in Accured Expenses has averaged -$16717.2 across 5 years, with a median of $2083.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 407346.38% — and 2024, when it tumbled 761.76%.
- Kamada's Change in Accured Expenses stood at -$276.0 in 2022, then soared by 407346.38% to $1.1 million in 2023, then jumped by 39.68% to $1.6 million in 2024, then slipped by 23.38% to $1.2 million in 2025, then slumped by 257.69% to -$1.9 million in 2026.
- The last three Change in Accured Expenses figures came in at -$1.9 million (Q1 2026), $1.2 million (Q4 2025), and $630000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | -1.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.90 Mn |
| Mar 31, 2026 | -1.90 Mn |
| Dec 31, 2025 | 1.20 Mn |
| Dec 31, 2025 | 1.20 Mn |
| Sep 30, 2025 | 630,000.00 |
| Sep 30, 2025 | 630,000.00 |
| Jun 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 881,000.00 |
| Sep 30, 2024 | 881,000.00 |
| Jun 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | -2.05 Mn |
| Mar 31, 2024 | -2.05 Mn |
| Dec 31, 2023 | 1.12 Mn |
| Dec 31, 2023 | 1.12 Mn |